Status:
COMPLETED
Conditions Associated With Poorly Controlled Diabetes in Patients With Type 2 Diabetes and HbA1c Changes With Therapy
Lead Sponsor:
Goztepe Training and Research Hospital
Conditions:
Type 2 Diabetes
Poorly Controlled Diabetes Mellitus
Eligibility:
All Genders
18-80 years
Brief Summary
In Turkey, only 55% of patients with type 2 diabetes have been diagnosed, and 91% of these patients have been receiving treatment. The rate of patients reaching the treatment target is 50%. The pandem...
Detailed Description
Patients who applied to Istanbul Medeniyet University Goztepe Prof. Dr. Suleyman Yalcin City Hospital Diabetes Polyclinics and have an HbA1c levels of \>= 10% in their examinations will be admitted to...
Eligibility Criteria
Inclusion
- diagnosed with type 2 diabetes
- give consent to the study
- accessibility to the previous and recent test results
Exclusion
- acute infection or inflammation lasting more than a week
- acute metabolic decompensation
- unable to attend to the follow-ups
- having non-thyroid endocrine diseases
- active oncologic treatment
Key Trial Info
Start Date :
August 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2022
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05394571
Start Date
August 15 2021
End Date
July 30 2022
Last Update
August 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Goztepe Prof. Dr. Suleyman Yalcin City Hospital
Istanbul, Turkey (Türkiye)